New MedRegs blog
MHRA has launched an official blog providing expert insight into the latest regulatory thinking and all aspects of medicines regulation.
If you’re working to develop and submit applications to MHRA for marketing authorisations and clinical trial authorisations, then you need to keep up to date with the latest regulatory thinking and be able to easily avoid common pitfalls.
Our blog will feature posts from experts who work right across the regulatory process. They’ll share their top insights and experience on a range of topics to help you stay informed, engage with our processes more effectively, and find out more about what we do to protect public health
We will be covering topics such as:
- submissions – how to get them right first time
- behind the scenes – find out more about how the regulator works
- key issues – the inside track on emerging issues for the regulation of medicines
Dr Siu Ping Lam, Director of Licensing, MHRA said:
Our MedRegs blog is another opportunity for us to connect directly with our stakeholders and customers in a less formal way, help them avoid common and easily avoidable errors and engage with us on issues that are important to them.
It also offers them an opportunity to share their thoughts and comments with us, and will encourage further two-way conversation between our regulatory specialists at MHRA and those working across industry, academia and healthcare.
We’d like to know what you think about our posts, so we can develop a really useful and informative blog. Let us know if you have ideas about what would be useful for us to cover.
Published: 9 February 2017